EP2560658

ENHANCING ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    21.4.2011
  • :
    22.2.2017
  • :
    11772735.4
  • :
    20.4.2031
  • :
    ENHANCING ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY

21.4.2011
22.2.2017
  • :
    VentiRx Pharmaceuticals, Inc.
  • :
    1191 Second Avenue, Suite 1105, 98101, Seattle, WA, US
  • :
    HERSHBERG, Robert
  • :
    Seattle, WA, US
  • :
    326406 P
  • :
    21.4.2010
  • :
    US
  • :
    US2011033500
  • :
    21.4.2011
  • :
    A61K 31/55, A61K 39/395, A61P 35/02, A61P 35/00, A61K 45/06, C07K 16/28, C07K 16/32